E-PROT-38
Ontology highlight
ABSTRACT:
PROVIDER: E-PROT-38 | ExpressionAtlas | 2022-01-06
REPOSITORIES: ExpressionAtlas
Dataset's files
| Action | DRS | |||
|---|---|---|---|---|
| E-PROT-38-analysis-methods.tsv | Tabular | |||
| E-PROT-38-configuration.xml | Xml | |||
| E-PROT-38-factors.xml | Xml | |||
| E-PROT-38-zoomifications-log.tsv | Tabular | |||
| E-PROT-38.condensed-sdrf.tsv | Tabular |
Items per page: 5 1 - 5 of 11 |
Similar Datasets
Project description:RNA-seq of 17 breast tumor samples of three different subtypes and normal human breast organoids samples
2025-01-24 | E-GEOD-52194 | ExpressionAtlas
Project description:Transcription profiling by array of histologically-normal human breast tissue
2025-01-16 | E-GEOD-10780 | ExpressionAtlas
Project description:Proteomics of pig heart and skeletal muscle tissue
2023-12-20 | E-PROT-131 | ExpressionAtlas
Project description:OLFM4 expression in breast tumor samples
2022-01-26 | E-PROT-72 | ExpressionAtlas
Project description:Protein expression in the dorsolateral prefrontal cortex of normal brain samples from the Johns Hopkins and Baltimore Coroner Aging Arm of Consensus Brain Proteomics Study
2021-05-20 | E-PROT-52 | ExpressionAtlas
Project description:Global gene expression profiles of 10 gastric cancer (GC) samples and 10 gastric normal adjacent tissue (gNAT) samples
2025-01-16 | E-MTAB-8135 | ExpressionAtlas
Project description:An atlas of the ageing lung mapped by single-cell transcriptomics and deep tissue proteomics
2022-01-14 | E-PROT-77 | ExpressionAtlas
Project description:Parkinson disease (PD) is a neurodegenerative disease characterized by the accumulation of alpha-synuclein (SNCA) and other proteins in aggregates termed âLewy Bodiesâ within neurons. PD has both genetic and environmental risk factors, and while processes leading to aberrant protein aggregation are unknown, past work points to abnormal levels of SNCA and other proteins. Although several genome-wide studies have been performed for PD, these have focused on DNA sequence variants by genome-wide association studies (GWAS) and on RNA levels (microarray transcriptomics), while genome-wide proteomics analysis has been lacking. After appropriate filters, proteomics identified 3,558 unique proteins and 283 of these (7.9%) were significantly different between PD and controls (q-value<0.05). RNA-sequencing identified 17,580 protein-coding genes and 1,095 of these (6.2%) were significantly different (FDR p-value<0.05), but only 166 of the FDR significant protein-coding genes (0.94%) were present among the 3,558 proteins characterized. Of these 166, eight genes (4.8%) were significant in both studies, with the same direction of effect. Functional enrichment analysis of the proteomics results strongly supports mitochondrial-related pathways, while comparable analysis of the RNA-sequencing results implicates protein folding pathways and metallothioneins. Ten of the implicated genes or proteins co-localized to GWAS loci. Evidence implicating SNCA was stronger in proteomics than in RNA-sequencing analyses. Notably, differentially expressed protein-coding genes were more likely to not be characterized in the proteomics analysis, which lessens the ability to compare across platforms. Combining multiple genome-wide platforms offers novel insights into the pathological processes responsible for this disease by identifying pathways implicated across methodologies. The study consists of mRNA-Seq (29 PD, 44 neurologically normal controls) and three-stage Mass Spectrometry Tandem Mass Tag Proteomics (12 PD, 12 neurologically normal controls) performed in post-mortem BA9 brain tissue. The proteomics samples are a subset of the RNA-Seq samples.
2016-01-15 | E-GEOD-68719 | biostudies-arrayexpress
Project description:Upon soy consumption, isoflavone metabolites attain bioactive concentrations in breast tissue possibly affecting health. Though in vitro epigenetic activity of soy metabolites has been described, the in vivo impact on the epigenome is largely unknown. Therefore, in this case-control study, the breast glandular tissue DNA methylome was explored in women undergoing an aesthetic breast reduction. After a run-in phase, 10 generally healthy Belgian or Dutch women received soymilk for 5 days. MethylCap-seq methylation profiles were compared with those of 10 matched controls. Isoflavones and their microbial metabolites were quantified in urine, serum, and glandular breast tissue (liquid chromatography-mass spectrometry) and 17β-estradiol in glandular breast tissue (immunoassay). Global DNA methylation levels were obtained for 6 cases and 5 controls using liquid chromatography-mass spectrometry. Although lower MethylCap-seq coverages were observed, mass spectrometry results and computational LINE-1 methylation analysis did not provide evidence supporting global methylation alterations upon treatment. At a false discovery rate of 0.05, no differentially methylated loci were identified. Moreover, a set of previously identified loci was specifically tested, but earlier reported results could not be validated. In conclusion, after a 5 day soymilk treatment, no epigenetic reprogramming in breast tissue could be found in this exploratory study.
2018-12-25 | GSE112727 | GEO
Project description:This dataset includes raw label-free mass spectrometry proteomics data of different sinonasal tumor entities as well as normal sinonasal tissue. 72 samples were processed on a Q Exactive HF-X instrument coupled to an easy nanoLC 1200 system using one microgram of peptides and an 110 minutes gradient.
| EGAD00010002381 | EGA